July 17th, 2008
Tissue Type Transglutaminase (TG2): Potential Therapeutic Target In Chemo-resistant Ovarian Cancer
University of Texas M. D. Anderson Cancer Center researchers have identified tissue type transglutaminase (TG2) as potential therapeutic target in chemotherapy-resistant ovarian cancer.
“….found overexpression of tissue type transglutaminase (TG2) in ovarian cancer is associated with increased tumor cell growth and adhesion, resistance to chemotherapy and lower overall survival rates.
When researchers targeted and silenced TG2 in […]
Recent Comments